GSK2606414 and GSK2656157 |
p-PERK↓, p-elF2α↓ |
Multiple myeloma |
[88, 89] |
STF-083010 |
Ire1 inhibitor |
Multiple myeloma |
[91] |
Sorafenib tyrosine kinase inhibitor (TKI) |
CHOP↑ GADD34↑; p-PERK↑; p-elF2α↑ |
L-428, L-1236, and KM-H2 cells |
[92] |
Sal003, inhibitor of phospho-eif2α phosphatase |
ATF4; p-elF2α↑ |
Glioblastoma cells |
[25] |
Diindolylmethane derivatives |
CHOP↑; DR5↑ |
Pancreatic cancer cells |
[93] |
Bortezomib proteasome inhibitor |
GRP78↑, CHOP↑, JNK↑, p-eIF2α↓ |
L3.6pl pancreatic cancer cells |
[94] |
Levistolide A |
ROS↑; CHOP↑ |
Colorectal cancer cells |
[97] |
Andrographolide |
ROS↑; CHOP↑ |
Colorectal cancer cells |
[99] |
Tolfenamic acid |
eIF2α↑; ATF4↑ |
Colorectal cancer cells |
[98] |
Cantharidin |
GRP78/BiP ↑, IRE1α ↑, IRE1β ↑, ATF6α ↑, XBP1 ↑ |
H460 |
[100] |
Carnosic acid |
ROS↑; CHOP↑; ATF4↑ |
Renal carcinoma Caki cells |
[101] |
Casticin |
CHOP ↑, p-eIF2α ↑, eIF2α ↑, GRP78/BiP ↑ |
BGC-823 |
[102] |
Cryptotanshinone |
p-eIF2α ↑, GRP94 ↑, GRP78 ↑, CHOP ↑, ROS↑ |
MCF7 |
[103] |
Curcumin |
CHOP ↑, GRP78/BiP ↑, ROS ↑ |
NCI-H460, HT-29, AGS |
[104, 105] |
Flavokawain B |
CHOP ↑, ATF4 ↑ |
HCT116 |
[106] |
Fucoidan |
CHOP ↑, ATF4 ↑, p-eIF2α ↑, GRP78/BiP ↓, p-IRE1 ↓, XBP1 ↓ |
MDA-MB-231 HCT116 |
[107] |
Furanodiene |
CHOP ↑, BIP ↑ |
A549, 95-D |
[108] |
2-3,4 Dihydroxyphenylethanol |
IRE1 ↑, XBP1 ↑, GRP78/BiP ↑, PERK ↑, eIF2α ↑, CHOP ↑ |
HT-29 |
[109] |
7-Dimethoxyflavone |
CHOP ↑, GPR78/BiP ↑, ATF4 ↑ |
Hep3B |
[110] |
SMIP004 (N-(4-butyl-2-methyl-phenyl) acetamide) |
ROS↑ IRE1↑; p-38↑; p-elF2α↑ |
Prostate cancer cells |
[111] |
Licochalcone A |
ATF6 ↑, eIF2α ↑, IRE1α ↑, CHOP ↑, GRP94 ↑, XBP1 ↑, GRP78/BiP ↑ |
HepG2 |
[112] |
Neferine |
GRP78/BiP ↑ |
Hep3B |
[113] |
Paeonol |
GRP78 ↑, CHOP ↑ |
HepG2 |
[114] |
Pardaxin |
ROS↑; p-PERK↑; p-elF2α↑ |
HeLa cells |
[115] |
Parthenolide |
ATF4 ↑, p-eIF2a ↑, eIF2α ↑ |
A549, Calu-1, H1299, H1792 |
[116] |
Piperine |
IRE1α ↑, CHOP ↑, GPR78/BiP ↑ |
HT-29 |
[117] |
Polyphenon E |
ATF4 ↑, PERK ↑, p-eIF2α ↑, eIF2α ↑, GRP78/BiP ↑, CHOP ↑, XBP1 ↑, ROS ↑ |
PC3, PNT1a |
[118] |
Polyphyllin D |
CHOP ↑, GRP78/BiP ↑, PDI ↑ |
NCI-H460 |
[119] |
Resveratrol |
GRP78/BiP ↑, CHOP ↑, XBP1 ↑, eIF2α ↑ |
HT29 |
[120] |
Dehydrocostuslactone |
p-PERK ↑, GRP78/BiP ↑, IRE1 ↑, CHOP ↑, XBP-1 ↑, ROS ↑ |
NCI-H460 A549 |
[121] |
γ-Tocotrienol |
CHOP ↑, GRP78/BiP ↑, XBP1 ↑ |
MDA-MB-231; MCF-7 |
[122] |
Ω-Hydroxyundec-9-enoic Acid (ω-HUA) |
ROS↑; CHOP↑ |
Lung cancer cells (H1299, A549, HCC827) |
[123] |
Ampelopsin |
ROS↑ GRP78↑; p-PERK↑; p-elF2α↑ |
Breast cancer cells (MCF-7; MDA-MB-231) |
[124] |
Ardisianone |
GRP78/BiP ↑ |
PC3 |
[125] |
Genistein |
CHOP ↑, GRP78/BiP ↑ |
Hep3B |
[126] |
Guttiferone H |
ATF4 ↑, XBP1 ↑, CHOP ↑ |
HCT116 |
[127] |
Guggulsterone |
ROS↑; p-eIF2α↑; CHOP↑ DR5↑ |
Liver cancer cells (Hep3B; HepG2) |
[128] |
Marchantin M |
GRP78/BiP, CHOP ↑, XBP1 ↑, p-eIF2α ↑, eIF2α ↑, ATF4 ↑, ATF6 ↑, ERAD ↓ |
PC3, DU145, LNCaP |
[129] |
Sarsasapogenin |
ROS↑; CHOP↑ |
HeLa cells |
[130] |
Saxifragifolin |
IRE1α ↑, XBP1 ↑, CHOP ↑, GRP78/BiP ↑, ROS↑ |
MDA-MB-231, MCF7 |
[131] |
Prodigiosin |
ROS↑; CHOP↑; p-eIF2α↑; PERK↑; GRP78↑; ATF6α↑, IRE1 ↑, eIF2a ↑ |
Pancreatic (8898); breast cancer cells (MCF-7 and MDA-MB-231) |
[132, 133] |
Quercetin |
GRP78/BiP ↑, ATF4 ↑, IRE1α ↑ ATF6 ↑ |
PC3 |
[134] |
Honokiol (HNK) |
ROS↑ p-eIF2α↑; GRP78↑ CHOP↑ |
Chondrosarcoma (JJ012 and SW1353); gastric (AGS, SCM-1 and MKN-45) cancer cells |
[135–139] |
Brefeldin A (BFA) |
ROS↑, IRE1α ↑, PERK ↑, XBP1↑; GRP78↑ CHOP↑ |
Ovarian (OVCAR-3); lung (A549); colorectal (colo 205); breast (MDA-MB-231) cancer cells |
[140–142] |
A-tocopheryl succinate |
SGC-7901 |
GRP78/BiP ↑, CHOP ↑ |
[143] |
Verrucarin A |
GRP78/BiP ↑, p-PERK ↑, p-eIF2α ↑, CHOP ↑ |
Hep3B, HepG2 |
[144] |
Vitamin E succinate |
GRP78/BiP ↑, GRP94 ↓, PERK ↑, ATF4 ↑, ATF6 ↑, XBP1 ↑, CHOP ↑ |
SGC-7901 |
[145] |
Ultrafine |
p-eIF2α ↑, GRP78/BiP ↑ |
SNU-484 |
[146] |
Zerumbone |
ATF4 ↑, CHOP ↑, GRP78/BiP ↑, p-PERK ↑, PERK ↑ eIF2α ↑, p-eIF2α ↑ |
HCT116-p53null, SW480, PC3 |
[68, 147] |